Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 87 trials
NCI-2022-06841
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
Adult (18-64)
Older adult (65+)
S2213
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Adult (18-64)
Older adult (65+)
EA3211
Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck
Adult (18-64)
Older adult (65+)
EAQ222CD
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Adult (18-64)
Older adult (65+)
Child (birth - 17)
S1900K
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Child (birth - 17)
Adult (18-64)
Older adult (65+)
CLN01001
Endovascular Engineering ENGULF Study
Adult (18-64)
Older adult (65+)
OCU400-301
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
Child (birth - 17)
Adult (18-64)
Older adult (65+)
61186372NSC2007
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Adult (18-64)
Older adult (65+)
RGX-314-3101
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Adult (18-64)
Older adult (65+)
NCI-2021-12653
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Adult (18-64)
Older adult (65+)